Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602

Authors

  • Giuseppa Penna Division of Haematology, University of Messina, Messina, Italy
  • Alessandro Allegra Division of Haematology, University of Messina, Messina, Italy
  • Giuseppa Romeo Divisione di Genetica Molecolare ed Immunologia dei Trapianti, Bianchi Melacrino Morelli Hospital, Reggio Calabria, Italy
  • Andrea Alonci Division of Haematology, University of Messina, Messina, Italy
  • Antonino Cannavò Division of Haematology, University of Messina, Messina, Italy
  • Sabina Russo Division of Haematology, University of Messina, Messina, Italy
  • Arianna D'Angelo Division of Haematology, University of Messina, Messina, Italy
  • Annamaria Petrungaro Division of Haematology, University of Messina, Messina, Italy
  • Caterina Musolino Division of Haematology, University of Messina, Messina, Italy

DOI:

https://doi.org/10.3109/0284186X.2011.640347

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2012-09-01

How to Cite

Penna, G., Allegra, A., Romeo, G., Alonci, A., Cannavò, A., Russo, S., … Musolino, C. (2012). Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602. Acta Oncologica, 51(7), 944–947. https://doi.org/10.3109/0284186X.2011.640347

Issue

Vol. 51 No. 7 (2012): Acta Oncologica

Section

Articles